Cargando...
Bibliografía NeoFarma

Se lista por orden alfabético la bibliografía general utilizada (como libros de texto, páginas web, y otras revisiones), y a continuación algunos artículos específicos consultados.

General

1. Cloherty, John. Manual of neonatal care.
6th edition

2. Ficha técnica de la Agencia Española del medicamento. Consultada en la web.
www.aemps.gob.es/cima; http://www.aemps.gob.es/cima/fichasTecnicas.do?metodo=detalleForm

3. Guía completa de consulta fármaco-terapeutica. Martindale. Tercera Edición.
Royal Pharmaceutical Society of Great
Britain. ISBN: 978-84-95993-20-5 Vento,
Máximo –Moro, Manuel De guardia en Neonatología. 2ª Edición 2008. Ed. Ergon

4. Medimecum. Guía de terapia farmacológica.
2010. Wolters Klluwer. Ed. Novartris.

5. Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life, 6th
Edition Edmund Hey (Editor) ISBN: 978-1-4051-9660-4. January 2011, BMJ Books

6. Neofax 2011 Young TE, Mangum B.. Montvale, NJ: Thomson Reuters

7. Pediatrc & neonatal Lexi-Drugs. Lexi-comp Inc. 2014

8. Pediatric Medication Handbook. Children´s
Hospital of the King´s Daughters http://www.chkd.org/documents/healthproresources/PedMedHandbook.pdf

9. Sola, Augusto. "Diálogos en neonatología"
ISBN: 9789872427597; Edimed, Argentina. 2010.

10. Sola, Augusto. "Cuidados neonatales:
Descubriendo la vida de un recién nacido".
ISBN: 9789872530341: 2 volumen. 1642 pages. Editorial Edimed, Argentina. 2011.

11. Sola Augusto. Compendio de Neonatología. ISBN 978998849275
Edimed, Argentina. 2013

12. Taketomo C, Hodding J, Kraus D. (2011-2012) Pediatric and neonatal dosage handbook. 18a Ed. Hudson OH: Lexi-Comp.

13. Texas Children’s Hospital. Drug information and formulary. 6th ed. Hudson: Lexi-Corp Inc,2001.

14. The Harriet Lane Handbook, 19th Edition.
ISBN: 978-0-323-07942-6 . 2012 . By Johns Hopkins Hospital, Kristin Arcara and Megan Tschudy

15. http://www.drugs.com/

16. https://www.unitypoint.org/blankchildrens/nicu-medications.aspx

17. http://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/clinical+resources/clinical+topics/neonatal+medication+guidelines

18. http://www.kemh.health.wa.gov.au/services/nccu/guidelines/drug_protocols.htm King Edward Memorial Hospital

19. http://pediamecum.es/

Artículos Revisados para Varias Drogas

1. Fox L, Wilder A, Foushee J. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.Am J Health-Syst Pharm—Vol 70 Mar 15, 2013

2. Wildschut ED, de Wildt SN, Mâthot RA, Reiss IK, Tibboel D, Van den Anker J. Effect of hypothermia and extracorporeal life support on drug disposition in neonates. Semin Fetal Neonatal Med. 2013 Feb;18(1):23-7.

3. Young TE, Mangum B. Neofax 2008, 21st ed. Montvale: Thomson Reuters, 2008.

4. Sola A. Cuidados neonatales: Descubriendo la vida de un recién nacido enfermo. 1ª ed. Buenos Aires: Edimed Ediciones Médicas, 2011.

5. Cohen-Wolkowiez M, Benjamin DK, Ross A, James LP, Sullivan JE, Walsh MC et al. Population pharmacokinetics of piperacillin using scavenged samples from preterm infants. Ther Drug Monit 2012; 34(3): 312-9.

6. Li Z, Chen Y, Li Q, Cao D, Shi W, Wu D.
Population pharmacokinetics of piperacillin / tazobactam in neonates and Young infants. Eur J Pharmacol 2013; 69(6): 1223-33.

7. Gransden WR, King A, Marossy D, Rosenthal E. Quinupristin / dalfopristin in neonatal Enterococcus faecium meningitis. Arch Dis Child Fetal Neonatal Ed 1998; 78(3): F235-6.

8. LeDoare K, Barber N, Doerholt K, Sharland M. Rifampicin pharmacokinetics in extreme prematurity to treat congenital tuberculosis. BMJ Case report 2013;

9. Rodriguez-Guerineau L, Salvia-Roigés MD, León-Lozano M, Rodríguez-Miguélez JM, Figueras-Aloy J. Combination of vancomycin and rifampicin for the treatment of persistent coagulase-negative staphylococcal bacteremia in preterm neonates. Eur J Pediatr 2013; 172(5): 693-7.

10. Soukka H, Rantakokko-Jalava K, Vãhãkuopus S, Ruuskanen O. Three distinct episodes of GBS septicemia en a healthy newborn during the first month of life. Eur J Pediatr 2010; 169(10): 1275-7.

11. Texas Children’s Hospital. Drug information and formulary. 6th ed. Hudson: Lexi-Corp Inc,2001.

12. Van der Lugt NM, Steggerda SJ, Walther FJ. Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonates. BMC Pediatr 2010; 10:84.

13. Sood S. Comparative avaluation of the in-vitro activity of six β-lactam / β-lactamase inhibitor combinations against Gram negative bacilli. J Clin Diagn Res2013; 7(2): 224-8.

14. Texas Children’s Hospital. Drug information and formulary. 6th ed. Hudson: Lexi-Corp Inc,2001.

15. Abdulhamid I, Wise TL, Andrews S, Biglin K, Lehr VT. Elevated serum tobramycin concentrations after treatment with tobramycin inhalation in a preterm infant. Pharmacotherapy 2008; 28(7): 939-44.

16. Pacifi GM. Clonical pharmacokinetics of aminoglycosides in the neonate: a review. Eur J Clin Pharmacol 2009; 65(4): 419-27.

17. Touati A, Achour W, Cherif A, Hmida HB, Afif FB, Jabnoun S et al. Outbreak of Acinetobacter baumannii in a neonatal intensive care unit: antimicrobial susceptibility and genotyping analysis. Ann Epidemiol 2009; 19(6): 372-8

18. Allegaert K, van der Anker JN. Creatinine-based vancomycin dosing regimens in neonates: there is more to consider tan the variation in drug assay. Pharmacotherapy 2012; 32(9): e174.

19. Rasigade JP, Bensaid M,Butin M, Picaud LC, Laurent F. Management of late-onset sepsis due to coagulase-negative staphylococci in neonatal intensive care units. Arch pediatr 2013; 20(9): 1028-33.

20. Stockmann C, Spigarelli MG, Campbell SC, Constance JE, Courter JD, Thorell EA et al. Considerations in the pharmacologic treatment and prevention of neonatal sepsis. Pediatr Drugs 2014; 16(1): 67-81.21. Zhao W, Lopez E, Biran V, Durrmeyer X, Fakhoury M, Jacqz-Aigrain E. Vancomycin continuous infusión in neonates: dosing optimisation and therapeutic drug monitoring. Arch Dis Child 2013; 98(6): 449-53.22. Kumar P, Denson SE, Mancuso TJ. Premedication for nonemergency endotracheal intubation in the neonate. Pediatrics. 2010;125:608–615.

23. Robertson CM, Tyebkhan JM, Peliowski A, Etches PC, Cheung PY. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr. 2006 Feb;95(2):214-23.

24. Feltman DM, Weiss MG, Nicoski P, Sinacore J. Rocuronium for nonemergent intubation of term and preterm infants. J Perinatol. 2011 Jan;31(1):38-43.

25. McEvoy C, Sardesai S, Schilling D, Durand M. Acute effects of vecuronium on pulmonary function and hypoxemic episodes in preterm infants. Pediatr Int. 2007 Oct;49(5):631-6.

26. Cools F, Offringa M. Neuromuscular paralysis for newborn infants receiving mechanical ventilation. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002773.

27. Cheung PY, Tyebkhan JM, Peliowski A, Ainsworth W, Robertson CMProlonged use of pancuronium bromide and sensorineural hearing loss in childhood survivors of congenital diaphragmatic hernia. J Pediatr.1999 Aug;135(2 Pt 1):233-9.

28. Allegaert K, Daniels H, Naulaers G, Tibboel D, Devlieger H. Pharmacodynamics of chloral hydrate in former preterm infants. Eur J Pediatr. 2005 Jul;164(7):403-7.

29. Litman RS, Soin K, Salam A. Chloral hydrate sedation in term and preterm infants: an analysis of efficacy and complications. Anesth Analg. 2010 Mar 1;110(3):739-46.

30. Tibboel D, Anand KJ, van den Anker JN. The pharmacological treatment of neonatal pain. Semin Fetal Neonatal Med. 2005 Apr;10(2):195-205.

31. Simons SH, Anand KJ. Pain control: opioid dosing, population kinetics and side-effects. Semin Fetal Neonatal Med. 2006 Aug;11(4):260-7.

32. Heald A, Abdel-Latif ME, Kent AL. Insulin infusion for hyperglycaemia in very preterm infants appears safe with no effect on morbidity, mortality and long-term
neurodevelopmental outcome. J Matern Fetal Neonatal Med. 2012 Nov;25(11):2415-8.

33. Sinclair JC, Bottino M, Cowett RM. Interventions for prevention of neonatal hyperglycemia in very low birth weight infants. Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007615.

34. Vemgal P, Ohlsson A. Interventions for non-oliguric hyperkalaemia in preterm neonates. Cochrane Database Syst Rev. 2012 May 16;5:CD005257.

35. Masilamani K, van der Voort J. The management of acute hyperkalaemia in neonates and children. Arch Dis Child. 2012 Apr;97(4):376-80.

36. Malone TA. Glucose and insulin versus cation-exchange resin for the treatment of hyperkalemia in very low birth weight infants. J Pediatr. 1991 Jan;118(1):121-3.

37. Miyake CY, Davis AM, Motonaga KS, Dubin AM, Berul CI, Cecchin F. Infant ventricular fibrillation after ST-segment changes and QRS widening: a new cause of sudden infant death? Circ Arrhythm Electrophysiol. 2013; 6(4):712-8.

38. Fox LM, Wilder AG, Foushee JA. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration. Am J Health Syst Pharm 2013; 70(6):520-4.

39. Seslar SP, Garrison MM, Larison C, Salerno JC. A multi-institutional analysis of inpatient treatment for supraventricular tachycardia in newborns and infants. Pediatr Cardiol. 2013; 34(2):408-14.

40. Dilber E, Mutlu M, Dilber B, Aslan Y, Gedik Y, Celiker A. Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants. Pediatr Emerg Care 2010; 26(2):82-4.

41. Wiegand G, Haber HP, Binder G, Kaulitz R, Hofbeck M. Ultrasound findings in newborns with amiodarone-induced hypothyroidism. Ultraschall Med 2009; 30(5):431-3.

42. Seslar SP, Garrison MM, Larison C, Salerno JC. A multi-institutional analysis of inpatient treatment for supraventricular tachycardia in newborns and infants. Pediatr Cardiol. 2013; 34(2):408-14.

43. Knudson JD, Cannon BC, Kim JJ, Moffett BS. High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias. Pediatr
Cardiol 2011; 32(7):896-903.

44. Filippi L, Cavallaro G, Fiorini P, Malvagia S, Della Bona ML, Giocaliere E, Bagnoli P, Dal Monte M, Mosca F, Donzelli G, la Marca G. Propranolol concentrations after oral administration in term and preterm neonates. J Matern Fetal Neonatal Med 2013; 26(8):833-40.

45. Chang PM, Silka MJ, Moromisato DY, Bar-Cohen Y. Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients. Circ Arrhythm Electrophysiol 2010; 3(2):134-40.

46. Moffett BS, Cannon BC, Friedman RA, Kertesz NJ. Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment. Pharmacotherapy 2006; 26(12):1687-93.

47. Jang DH, Hoffman RS, Nelson LS. A case of near-fatal flecainide overdose in a neonate successfully treated with sodium bicarbonate. J Emerg Med 2013; 44(4):781-3.

48. Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P et al. Flecainide as first-line treatment for supraventricular tachycardia in newborns. J Cardiovasc Med
(Hagerstown) 2009; 10(5):372-5.

49. Vento M, Tudela BF, Escrig R, Sáenz P, Sánchez A, Cano A. Haemolysis alters plasma flecainide levels in newborn infants.

50. Acta Paediatr 2007; 96(3):466-8.

51. Semin Fetal Neonatal Med. 2006 Aug;11(4):260-7

52. Cuzzolin L, Antonucci R, Fanos V. Paracetamol (acetaminophen) efficacy and safety in the newborn Curr Drug Metab. 2013 Feb;14(2):178-85

53. Atropina: Pediatrics. 2011 Apr;127(4):783-4.

54. Dornasa: J Perinatol. 2000 Dec;20(8 Pt 1):530-4

55. Ann Saudi Med. 2012 Mar-Apr;32(2):131-6

56. Croat Med J. 2007 Apr;48(2):234-9

57. Pediatr Int. 2011 Jun;53(3):328-31. doi: 10.1111/j.1442-200X.2010.03245.

58. Stark AR, et al Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants. J Pediatr. 2014 Jan;164(1):34-39.e2.

59. Puckett RN, Offringa M. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Library 2000; Issue 4.

60. Pereira SP, Shearer MJ, Williams R, Lieli-Vergani G. Intestinal absortion of mixed micellar phylloquinone (vitamin K1)is unreliable in infants with conjugated
hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding. Arch Dis Child Fetal Neonatal Ed 2003; 88(2): F113-8.

61. Raith W, Fauler G, Pichler G, Muntean W. Plasma concentrations after intravenous administration of phylloquinone (vitamin K1) in preterm and sick neonates. Thromb Res
2000; 99(5): 467-72.

62. Schubiger G, Grüter J, Shearer MJ. Plasma vitamin K1 and PIVKA-II after oral administration of mixed-micellar or cremophor Elsolubilized preparations of vitamin K1 to
normal breast-fed newborns. J Pediatr Gastroenterol Nutr 1997; 24(3): 280-4.

63. Meyn DF Jr1, Ness J, Ambalavanan N, Carlo WA. Prophylactic phenobarbital and whole-body cooling for neonatal hypoxicischemic encephalopathy. J Pediatr. 2010 Aug;157(2):334-6.

64. van den Broek MP, Rademaker CM, van Straaten HL, Huitema AD, Toet MC, de Vries LS, Egbert s AC, Groenendaal F. Anticonvulsant treatment of asphyxiated newborns under hypothermia with lidocaine: efficacy, safety and dosing. Arch Dis Child Fetal Neonatal Ed. 2013 Jul;98(4):F341-5.

65. Barks JD1, Liu YQ, Shangguan Y, Silverstein FS. Phenobarbital augments hypothermic neuroprotection. Pediatr Res. 2010 May;67(5):532-7.

66. Golombek SG, Fariña D, Sola A, Baquero H, Cabañas F, Dominguez F, et al. Segundo Consenso Clínico de la Sociedad Iberoamericana de Neonatología: manejo hemodinámico del recién nacido. Rev Panam Salud Publica. 2011;29(4):281–302.

67. Miller JL, Gormley AK, Johnson PN. Pantoprazole-induced thrombocytopenia. Indian J Pediatr. 2009 Dec;76(12):1278-9.

68. Kierkus J, Furmaga-Jablonska W, Sullivan JE, David ES, Stewart DL, Rath N, Fu C, Wang W, Maguire MK, Comer GM. Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11 months with a clinical diagnosis of gastroesophageal reflux disease. Dig Dis Sci. 2011 Feb;56(2):425-34.

69. Ward RM, Kearns GL. Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs. 2013 Apr;15(2):119-31.

70. Perkins MD, Edwards KM, Heller RM, Green NE. Neonatal group B streptococcal osteomyelitis and suppurative arthritis. Outpatient therapy. Clin Pediatr (Phila). 1989
May;28(5):229-30

71. Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet
Gynecol. 1989 Apr;73(4):583-7.

72. Zaidi AK, Tikmani SS, Warraich HJ, Darmstadt GL, Bhutta ZA, Sultana S, Thaver D. Community-based treatment of serious bacterial infections in newborns and young infants: a randomized controlled trial assessing three antibiotic regimens. Pediatr Infect Dis J. 2012 Jul;31(7):667-72.

73. Haque KN, Pammi M. Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev. 2011 Oct 5;(10):CD004205.

74. Harris E, Schulzke SM, Patole SK. Pentoxifylline in preterm neonates: a systematic review. Paediatr Drugs. 2010 Oct 1;12(5):301-11.

75. Diagnóstico y tratamiento de sepsis y choque séptico del recién nacido en el segundo y tercer nivel de atención. México, Secretaría de Salud 2012.

76. Lemyre B, Cheng R, Gaboury I. Atropine, fentanyl and succinylcholine for non-urgent intubations in newborns. Arch Dis Child Fetal Neonatal Ed. 2009 Nov;94(6):F439-42.

77. Karlsson R, Kalllio J, Irjala K, et al. Adrenocorticotropin and corticotropin-releasing hormone tests in preterm infants. J Clin Endocrinol Metab 2000;85:4592–5.

78. Norman E, Wikström S, Hellström-Westas L, Turpeinen U, Hämäläinen E, Fellman V. Rapid sequence induction is superior tomorphine for intubation of preterm infants: a
randomized controlled trial. J Pediatr. 2011 Dec;159(6):893-9.

79. Mossad E, Motta P, Sehmbey K, Toscana D. The hemodynamic effects of phenoxybenzamine in neonates, infants, and children.J Clin Anesth. 2008 Mar;20(2):94-8.

80. Srinivasan C, Sachdeva R, Morrow WR, Gossett J, Chipman CW, Imamura M, Jaquiss RD. Standardized management improvesoutcomes after the Norwood procedure. Congenit Heart Dis. 2009 Sep-Oct;4(5):329-37.

81. Vemgal P, Ohlsson A. Interventions for non-oliguric hyperkalaemia in preterm neonates. Cochrane Database Syst Rev. 2012 May 16;5:CD005257.

82. Sola A. Cardetti M. Resolviendo dudas del Cuidado Neonatal en Latinoamérica a travez de Facebook – Año 2017 - 2018

83. Battin M, Jamalpuri V, Bough G, Voss L. Antibiotic prophylaxis and neonatal surgical site infection. J Paediatr Child Health. 2016 Sep;52(9):913-4. doi: 10.1111/jpc.13285.

84. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI supplement M100 (ISBN 1-56238-804-5 [Print]; ISBN 1-56238-805-3 [Electronic]). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2017.

85. Cochrane Database of Systematic Reviews 2018 Paracetamol (acetaminophen) for patent dusctus arteriosus in preterm or low birth weight infants (Review) Issue 4 Art. No.CD010061

86. Yozawitz E, Stacey A, Pressler RM. Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy. Paediatr Drugs. 2017; 19:553-567

87. Mutlu M, Aslan Y, Aktürk Acar F, Kader Ş, Bayramoğlu G, Yılmaz G. Changing trend of microbiologic profile and antibiotic susceptibility of the microorganisms isolated in the neonatal nosocomial sepsis: a 14 years analysis. J Matern Fetal Neonatal Med. 2019 Mar 4:1-8

88. El-Segaier M, Khan MA, Khan ZU, Momenah T, Galal MO. Recombinant Tissue Plasminogen Activator in the Treatment of Neonates with Intracardiac and Great Vessels Thrombosis. Pediatr Cardiol. 2015 Dec;36(8):1582-7. doi: 10.1007/s00246-015-1199-0. Epub 2015 May 21

89. Rossaint R. et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Criti cal Care, 2016; 20:100 DOI 10.1186/s13054-016-1265-x

90. Lambert MP. Chapter 3, Special Disease Considerations in the Neonate. En: Deborah A. Sesok-Pizzini. Neonatal Transfusion Practices. Philadelphia. Springer. 2017. 47 – 62.

91. Bassler D, Playka R, Shinwell E, Hallman M, Jarreau P, Carnielli V, Van Den Anker J, Meisner C, Engerl C, Schwab M, Halliday H, Poets C. Grupo NEUROSIS. Budesonida inhalada precoz para la prevención de la displasia broncopulmonar. N Engl J Med 2015; 373:1497-1506 DOI: 10.1056 / NEJMoa1501917

92. Romantsik O, Calevo MG, Norman E, Bruschettini M.Clonidine for sedation and analgesia for neonates receiving mechanical ventilation. Cochrane Database of Systematic
Reviews 2017, Issue 5. Art. No.: DOI: 10.1002/14651858.CD012468.pub2.

93. Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews 2017, Issue 10. Art. No.: CD001145. DOI: 10.1002/14651858.CD001145.pub4

94. Fariña D, Mir R, Lemus L, Golombek S, Sola A. y colaboradores del Consenso Clínico SIBEN, VIII Consenso Clínico SIBEN: Displasia Broncopulmonar, 2016 EDISIBEN, Paraguay, ISBN 978-1-5323-0307-8.

95. Afrin, M .Role of Sodium Bicarbonate to Treat Neonatal Metabolic Acidosis: Beneficial or Not J Bangladesh Coll Phys Surg 2017; 35: 80-85.

96. Sola A, Golombek SG. CUIDANDO ALRECIÉN NACIDO ALAMANERADE SIBEN TOMO I. EDISIBEN. Bolivia 2017; ISBN:
978-1-5323-3453-5.

97. BNF for Children (BNFC) 2017-2018). London: Pharmaceutical Press, 2017; 978 0 85711 322 1 (ePDF)

98. Speer EM, Dowling DJ, Xu J, Lukasz S, Mathew JA, Chander A, Donglei Yin, Levy O. Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age dependent and synergistic inhibition of TLR and inflammasome-mediated cytokine production in human newborn and adult blood in vitro. PLOS ONE | https://doi.org/10. 1371/journal.pone.0196352 May 1, 2018. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29715306

99. K. Guerrier, P. Shamszad, R.J. Czosek, D.S. Spar, T.K. Knilans, J.B. Anderson Variation in antiarrhythmic management of infants hospitalized with supraventricular tachycardia:
A multi-institutional analysis. Pediatr Cardiol., 37 (2016), pp. 946-952 http://dx.doi.org/10.1007/s00246-016-1375-x

100. Martin L. The basic principles of anesthesia for the neonate. Colombian Journal of Anesthesiology, Volume 45, Issue 1, January–March 2017, Pages 54-61
doi.org/10.1016/j.rca.2016.07.006

101. Crit Rev Anal Chem. 2016 Jul 3;46(4):352-60. doi: 10.1080/1040834 7.2015.1084225. Epub 2015 Sep 4. A Critical Review of the Properties of Fusidic Acid and Analytical Methods for Its Determination. Curbete MM1, Salgado HR1.

102. Kosinova M et al. Rocuronium versus suxamethonium for rapid sequence induction of general anaesthesia for caesarean section: influence on neonatal outcomes. Int J Obstet Anesth. 2017; 32: 4-10

103. Fariña D, Golombek S, Mir R, Sola A. y Miembros del Consenso Clínico de la Sociedad Ibero-Americana de Neonatología (SIBEN) Recomendaciones de VIII
Consenso Clínico de SIBEN para la Displasia Broncopulmonar. NeoReviews 2018; 19; e 712 DOI:10.1542/neo.19-11-e712

104. Ortiz j, Lara G , Sola A. Infectologia Perinatal y Neonatal. EDISIBEN. Mexico 2015; 7980908646974.

105. Laituri C, Arnold MA. Astandardized guideline for antibiotic prophylaxis in surgical neonates. Semin Pediatr Surg. 2019 Feb;28(1):53-56. doi: 10.1053/j.sempedsurg.2019.01.009. Epub 2019 Jan 23. PMID: 30824135

106. Mutlu M, Aslan Y, Aktürk Acar F, Kader Ş, Bayramoğlu G, Yılmaz G. Changing trend of microbiologic profile and antibiotic susceptibility of the microorganisms isolated in the neonatal nosocomial sepsis: a 14 years analysis. J Matern Fetal Neonatal Med. 2019 Mar 4:1-8. doi: 10.1080/14767058.2019.1582633. [Epub ahead of print

107. Blanchard AC, Fortin E, Laferrière C, Goyer I, Moussa A, Autmizguine J, Quach C. Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negati ve staphylococcal central-line-associated bloodstream infections in a neonatal intensive care unit. J Antimicrob Chemother. 2017 Jun 1;72(6):1812-1817. doi: 10.1093/jac/dkx059